Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 82
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Liver Transpl ; 29(9): 940-951, 2023 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-37016761

RESUMEN

Fluorescence confocal microscopy (FCM) is a rapidly evolving tool that provides real-time virtual HE images of native tissue. Data about the potential of FCM as an alternative to frozen sections for the evaluation of donor liver specimens are lacking so far. The aim of the current study was to determine the value of FCM in liver specimens according to the criteria of the German Society for Organ Procurement. In this prospective study, conventional histology and FCM scans of 50 liver specimens (60% liver biopsies, 26% surgical specimens, and 14% donor samples) were evaluated according to the German Society for Organ Procurement. A comparison of FCM scans and conventional frozen sections revealed almost perfect levels of agreement for cholangitis (κ = 0.877), fibrosis (κ = 0.843), and malignancy (κ = 0.815). Substantial levels of agreement could be obtained for macrovesicular steatosis (κ = 0.775), inflammation (κ = 0.763), necrosis (κ = 0.643), and steatohepatitis (κ = 0.643). Levels of agreement were moderate for microvesicular steatosis (κ = 0.563). The strength of agreement between frozen sections and FCM was superior to the comparison of conventional HE and FCM imaging. We introduce FCM as a potential alternative to the frozen section that may represent a novel approach to liver transplant pathology where timely feedback is crucial and the deployment of human resources is becoming increasingly difficult.


Asunto(s)
Hígado Graso , Trasplante de Hígado , Humanos , Trasplante de Hígado/efectos adversos , Estudios Prospectivos , Donadores Vivos , Biopsia , Hígado Graso/patología , Microscopía Confocal/métodos
2.
Int J Cancer ; 150(8): 1341-1349, 2022 04 15.
Artículo en Inglés | MEDLINE | ID: mdl-34807464

RESUMEN

Metastatic colorectal cancer (mCRC) patients with liver-limited disease (LLD) have a chance of long-term survival and potential cure after hepatic metastasectomy. However, the appropriate postoperative treatment strategy is still controversial. The CELIM and FIRE-3 studies demonstrated that secondary hepatic resection significantly improved overall survival (OS). The objective of this analysis was to compare these favorable outcome data with recent results from the LICC trial investigating the antigen-specific cancer vaccine tecemotide (L-BLP25) as adjuvant therapy in mCRC patients with LLD after R0/R1 resection. Data from mCRC patients with LLD and secondary hepatic resection from each study were analyzed for efficacy outcomes based on patient characteristics, treatment and surveillance after surgery. In LICC, 40/121 (33%) patients, in CELIM 36/111 (32%) and in FIRE-3-LLD 29/133 (22%) patients were secondarily resected, respectively. Of those, 31 (77.5%) patients in LICC and all patients in CELIM were R0 resected. Median disease-free survival after resection was 8.9 months in LICC, 9.9 months in CELIM. Median OS in secondarily resected patients was 66.1 months in LICC, 53.9 months in CELIM and 56.2 months in FIRE-3-LLD. Median age was about 5 years less in LICC compared to CELIM and FIRE-3. Secondarily resected patients of LICC, CELIM and FIRE-3 showed an impressive median survival with a tendency for improved survival for patients in the LICC trial. A younger patient cohort but also more selective surgery, improved resection techniques, deep responses and a close surveillance program after surgery in the LICC trial may have had a positive impact on survival.


Asunto(s)
Neoplasias Colorrectales/secundario , Neoplasias Colorrectales/terapia , Terapia Combinada/métodos , Neoplasias Hepáticas/secundario , Neoplasias Hepáticas/terapia , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Vacunas contra el Cáncer/uso terapéutico , Europa (Continente) , Femenino , Hepatectomía/métodos , Humanos , Masculino , Glicoproteínas de Membrana/uso terapéutico , Metastasectomía/métodos , Persona de Mediana Edad , Ensayos Clínicos Controlados Aleatorios como Asunto
3.
Langenbecks Arch Surg ; 406(1): 141-152, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-33210209

RESUMEN

PURPOSE: The management of patients with suspected appendicitis remains a challenge in daily clinical practice, and the optimal management algorithm is still being debated. Negative appendectomy rates (NAR) continue to range between 10 and 15%. This prospective study evaluated the accuracy of a diagnostic pathway in acute appendicitis using clinical risk stratification (Alvarado score), routine ultrasonography, gynecology consult for females, and selected CT after clinical reassessment. METHODS: Patients presenting with suspected appendicitis between November 2015 and September 2017 from age 18 years and above were included. Decision-making followed a clear management pathway. Patients were followed up for 6 months after discharge. The hypothesis was that the algorithm can reduce the NAR to a value of under 10%. RESULTS: A total of 183 patients were included. In 65 of 69 appendectomies, acute appendicitis was confirmed by histopathology, corresponding to a NAR of 5.8%. Notably, all 4 NAR appendectomies had other pathologies of the appendix. The perforation rate was 24.6%. Only 36 patients (19.7%) received a CT scan. The follow-up rate after 30 days achieved 69%, including no patients with missed appendicitis. The sensitivity and specificity of the diagnostic pathway was 100% and 96.6%, respectively. The potential saving in costs can be as much as 19.8 million €/100,000 cases presenting with the suspicion of appendicitis. CONCLUSION: The risk-stratified diagnostic algorithm yields a high diagnostic accuracy for patients with suspicion of appendicitis. Its implementation can safely reduce the NAR, simultaneously minimizing the use of CT scans and optimizing healthcare-related costs in the treatment of acute appendicitis. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02627781 (December 2015).


Asunto(s)
Apendicitis , Enfermedad Aguda , Algoritmos , Apendicectomía , Apendicitis/diagnóstico por imagen , Apendicitis/cirugía , Femenino , Humanos , Recién Nacido , Estudios Prospectivos , Sensibilidad y Especificidad , Ultrasonografía
4.
Unfallchirurg ; 124(8): 621-626, 2021 Aug.
Artículo en Alemán | MEDLINE | ID: mdl-34374807

RESUMEN

Hemorrhage after trauma in the area of the upper abdominal organs and the kidneys can represent a life-threatening situation. The primary treatment options are conservative or surgical treatment. Only in exceptional cases can endovascular treatment with an angiographic depiction of the active bleeding and, if necessary, intervention by means of embolization be used as an alternative.


Asunto(s)
Traumatismos Abdominales , Embolización Terapéutica , Traumatismos Abdominales/diagnóstico por imagen , Traumatismos Abdominales/cirugía , Angiografía , Hemorragia/diagnóstico por imagen , Hemorragia/terapia , Humanos , Riñón/diagnóstico por imagen , Estudios Retrospectivos , Resultado del Tratamiento
5.
Digestion ; 101(4): 458-465, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31129660

RESUMEN

BACKGROUND: Incidence of cholangiocarcinoma (CCA) in western countries is rising. In the palliative setting, chemotherapy is the only established treatment. The evidence for other treatments including locoregional therapy is low. However, such individual treatments are offered in a real-world setting. The aim of this study is to document the offered treatments and to analyze the survival of patients with unresectable CCA treated at a tertiary referral center. PATIENTS AND METHODS: Data from 220 consecutive patients with CCA treated at a German university cancer center from January 1, 2008, until December 31, 2012. Of those, 105 patients were unresectable. Survival curves were calculated according to the Kaplan-Meier method; log-rank test was applied for survival analysis. RESULTS: Any palliative treatment was beneficial for patients with unresectable CCA when compared to best supportive care (BSC) alone; median OS with BSC was 10 weeks (BSC vs. transarterial chemoembolization [TACE] p = 0.017, HR 0.36; BSC vs. TACE/chemotherapy p < 0.001, HR 0.24; BSC vs. chemotherapy p < 0.001, HR 0.31). Combination of TACE and chemotherapy prolonged overall survival as compared to TACE alone (105 vs. 43 weeks, p = 0.045). CONCLUSION: Prognosis in advanced stage CCA is still very poor. However, multimodal treatment in palliative patients significantly prolong survival.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias de los Conductos Biliares/mortalidad , Quimioembolización Terapéutica/mortalidad , Colangiocarcinoma/mortalidad , Cuidados Paliativos/estadística & datos numéricos , Anciano , Anciano de 80 o más Años , Neoplasias de los Conductos Biliares/terapia , Colangiocarcinoma/terapia , Terapia Combinada , Femenino , Humanos , Masculino , Cuidados Paliativos/métodos , Pronóstico , Estudios Retrospectivos , Centros de Atención Terciaria/estadística & datos numéricos , Resultado del Tratamiento
6.
Heart Surg Forum ; 23(6): E786-E788, 2020 Oct 19.
Artículo en Inglés | MEDLINE | ID: mdl-33234205

RESUMEN

A 46-year-old male received total arch replacement with frozen elephant trunk for acute non-A/non-B aortic dissection. Two months later, he underwent emergency reoperation for contained rupture of the left common carotid ostium at its insertion on the aortic arch. Three months after the reoperation, he developed tracheoesophageal fistula and infection of the prosthesis in the region of the aortic arch and the proximal descending aorta. Second reoperation was performed with replacement of the aorta with a composite of three aortic homografts, and the fistula was permanently closed with a direct suture and intercostal muscle flap.


Asunto(s)
Aneurisma Infectado/cirugía , Aorta Torácica/cirugía , Aneurisma de la Aorta Torácica/cirugía , Disección Aórtica/cirugía , Prótesis Vascular , Aloinjertos , Disección Aórtica/diagnóstico , Aneurisma Infectado/diagnóstico , Aneurisma de la Aorta Torácica/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Tomografía de Emisión de Positrones , Diseño de Prótesis , Reoperación , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
7.
Zentralbl Chir ; 145(1): 48-56, 2020 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-31559621

RESUMEN

BACKGROUND: Colorectal foreign bodies are commonly seen in the emergency department. A delayed consultation may be associated with a worse outcome. Despite a low-lying position, the extraction can be a challenge and has to be done under general anesthesia. Sharp or potentially dangerous foreign bodies should be excluded before extraction manoeuvres and complications have to be ruled out after the retrieval. METHOD: Data were retrospectively collected from 2002 to 2017. Overall 33 patients were included. In addition, a systematic search, employing the PRISMA criteria, was performed. The search was carried out on PubMed (1623), Cochrane Library (17) and Google Scholar (300). Case reports, papers not written in English and publications before 1980 were excluded. RESULTS: With an average delay of 33 h, patients admitted themselves to the emergency department. Attempts to remove foreign bodies in the emergency department were successful in 2 cases (6%). General anaesthesia was required in 31 (94%) patients. An emergency laparotomy was necessary in 3 cases (9%). No complications were noticed. CONCLUSION: A delayed consultation is not associated with a worse outcome. Complications should be ruled out by endoscopy. After a normal control, the patient can be discharged prematurely without further imaging.


Asunto(s)
Cuerpos Extraños , Anestesia General , Neoplasias Colorrectales , Endoscopía , Humanos , Estudios Retrospectivos
8.
Zentralbl Chir ; 144(3): 259-263, 2019 Jun.
Artículo en Alemán | MEDLINE | ID: mdl-31167269

RESUMEN

In the absence of extrahepatic metastases, improved survival can be achieved with surgical and interventional techniques. In resectable patients the resection of liver metastases can be performed in curative intention. Interventional techniques are defined either as percutaneous or intraoperative laparoscopy, applications of thermal ablation. In this review, we concentrate on the most established ablative techniques of radiofrequency ablation (RFA) and microwave ablation (MWA) for the treatment of colorectal liver metastases. These techniques allow safe ablation of metastases of up to 3 cm and have a low complication rate. In the current recommendations and guidelines, interventional therapies can be used for tumours that are surgically difficult to resect, in combination with surgery to reduce the surgical trauma or - in case of recurrent metastases - to avoid complicated repeat surgeries. Interventional therapies in combination with chemotherapy are superior to chemotherapy alone and should be considered especially in irresectable situations.


Asunto(s)
Ablación por Catéter , Neoplasias Colorrectales , Laparoscopía , Neoplasias Hepáticas , Hepatectomía , Humanos , Neoplasias Hepáticas/terapia , Reoperación , Resultado del Tratamiento
9.
Digestion ; 98(4): 263-269, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30130797

RESUMEN

BACKGROUND: Initially unresectable colorectal liver metastases can become resectable after chemotherapy. Combination chemotherapy with epidermal growth factor receptor (EGFR) antibodies has shown consistent high response rates in patients with all rat sarcoma (RAS) wild-type tumors. METHODS: Out of a cohort of 424 patients with metastatic colorectal cancer, we identified 30 patients with initially unresectable Kirsten RAS (KRAS) exon 2 wild-type colorectal liver metastases who received neoadjuvant chemotherapy with anti-EGFR agents between January 2008 and February 2014. In all patients, extended RAS analysis (KRAS and NRAS exon 3 codon 59/61 and exon 4 codon 117/146) was carried out retrospectively. RESULTS: RAS mutation analysis identified further KRAS mutations in 4/30 patients (13.3%). In none of these 4 patients a R0 resection was achieved. In contrast, 15/26 (57.7%) RAS wild-type patients were R0 resected. Median overall survival was > 63.3 months in R0-resected patients versus 30.0 months in those with a R1 or R2 resection (HR 0.23; [95% CI 0.10-0.75; p = 0.008). CONCLUSION: Our data suggest that a RAS wild-type and a R0 resection are the strongest predictors for overall survival.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Neoplasias Colorrectales/terapia , Hepatectomía/estadística & datos numéricos , Neoplasias Hepáticas/terapia , Carga Tumoral/efectos de los fármacos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias Colorrectales/genética , Neoplasias Colorrectales/mortalidad , Neoplasias Colorrectales/patología , Análisis Mutacional de ADN/métodos , Receptores ErbB/antagonistas & inhibidores , Exones/genética , Femenino , GTP Fosfohidrolasas/genética , Humanos , Hígado/efectos de los fármacos , Hígado/cirugía , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/mortalidad , Neoplasias Hepáticas/secundario , Masculino , Proteínas de la Membrana/genética , Persona de Mediana Edad , Mutación , Terapia Neoadyuvante/métodos , Proteínas Proto-Oncogénicas p21(ras)/genética , Estudios Retrospectivos , Análisis de Supervivencia , Carga Tumoral/genética
10.
Langenbecks Arch Surg ; 403(1): 73-82, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28493145

RESUMEN

PURPOSE: The relationship between the body mass index (BMI) of kidney transplant recipients and outcomes after kidney transplantation (KT) is not fully understood and remains controversial. We studied the influence of BMI on clinically relevant outcomes in kidney transplant recipients. METHODS: In this retrospective single-centre study, all patients who underwent kidney transplantation at our institution between January 2007 and December 2012 were included. Demographic data and BMI were correlated with the clinical course of the disease, rejection rates, delayed graft function rates, and graft and patient survival. RESULTS: During the study period, 384 single KTs (130 women and 254 men) were performed. Seventeen percent of the transplants were transplanted within the Eurotransplant Senior Programme (ESP). Most of the transplants were performed using organs that were obtained from donors after brain death (DBD), and living donor kidney transplants were performed in 22.4% of all transplants. The median BMI of the recipients was 25.9 kg/m2. Additionally, 13.5% of the recipients had a BMI of 30-34.9 kg/m2 and 3.9% had a BMI >35 kg/m2. A BMI >30 kg/m2 was significantly associated with primary non-function of the kidney (p = 0.047), delayed graft function (p = 0.008), and a higher rate of loss of graft function (p = 0.015). The glomerular filtration rate 12 months after KT was significantly lower in recipients with a BMI >30 kg/m2. Multivariate analysis revealed that recipient BMI, among other factors, was an independent risk factor for delayed graft function and graft survival. Patients with a BMI >30 kg/m2 had an almost four times higher risk for surgical site infection than did recipients with a lower BMI. CONCLUSIONS: Increased BMI at kidney transplantation is a predictor of adverse outcomes, including delayed graft function. These findings demonstrate the importance of the careful selection of patients and pre-transplant weight reduction, although the role of weight reduction for improving graft function is not clear.


Asunto(s)
Enfermedades Renales/complicaciones , Enfermedades Renales/cirugía , Trasplante de Riñón/efectos adversos , Obesidad/complicaciones , Complicaciones Posoperatorias/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Índice de Masa Corporal , Funcionamiento Retardado del Injerto/epidemiología , Femenino , Tasa de Filtración Glomerular , Rechazo de Injerto/epidemiología , Supervivencia de Injerto , Humanos , Enfermedades Renales/mortalidad , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Tasa de Supervivencia , Resultado del Tratamiento , Adulto Joven
11.
BMC Med Educ ; 18(1): 237, 2018 Oct 11.
Artículo en Inglés | MEDLINE | ID: mdl-30314497

RESUMEN

BACKGROUND: This study assessed the impact of medical students' emotion recognition ability and extraversion on their empathic communication, as perceived by simulated patients in a training context. METHODS: This study used a crossed-effect data structure and examined 245 students in their fourth year of medical school. The students' personality traits were assessed based on a self-assessment questionnaire of the short form of the Big Five Inventory; their emotion recognition ability was measured using a performance test (Diagnostic Analysis of Nonverbal Accuracy-2, Adult Facial Expressions). Simulated patients evaluated the medical students' empathic communication. RESULTS: Students with a combination of high emotion recognition ability and extraversion received more positive ratings from simulated patients than their fellow students with a combination of emotion recognition ability and low extraversion. The main effects of emotion recognition or extraversion were not sufficient to yield similar effects. There were no other effects related to the remaining Big Five variables. CONCLUSIONS: The results support the hypothesis that to build rapport with patients, medical staff need to combine emotional capabilities with a dispositional interest in interpersonal encounters.


Asunto(s)
Empatía , Extraversión Psicológica , Simulación de Paciente , Relaciones Médico-Paciente , Estudiantes de Medicina/psicología , Adulto , Anciano , Comunicación , Educación de Pregrado en Medicina , Femenino , Humanos , Relaciones Interpersonales , Masculino , Persona de Mediana Edad , Personalidad , Autoevaluación (Psicología) , Servicio de Cirugía en Hospital , Encuestas y Cuestionarios
12.
Int J Colorectal Dis ; 32(9): 1303-1311, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28710611

RESUMEN

PURPOSE: Bacterial infections are a factor for morbidity in patients with acute appendicitis (AA). The spreading of multidrug-resistant (MDR) bacteria is a significant problem in surgery, and the most relevant MDR pathogens are summarized as Enterobacteriaceae, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterococci (ESKAPE) bacteria. Data regarding the species and distribution of bacteria in AA are available, but information about the resistances and their relevance is deficient. METHODS: In this retrospective study, we analyzed microbiological swabs of patients with AA. The outcome parameters of patients after laparoscopic appendectomy were analyzed against microbiological results, including antibiotic resistance testing. Positive swabs were compared with bacteria cultivated after alternative abdominal emergency surgery (AES). RESULTS: In total, 584 patients with AA were included and had a mean age of 35.5 years. In 216 patients (36.9%), a swab was taken, and in 128 (59.3%) swabs, bacteria could be cultivated. The most frequent organisms were Escherichia coli, Bacteroides species, and Pseudomonas. In 9.4% of the positive AA swabs, MDR germs were cultivated, and all of them were ESKAPE pathogens. Patients with MDR bacteria in AA suffered more infectious complications (p = 0.006) and needed longer hospitalizations (p < 0.009). In AES, aside from appendicitis, a different spectrum containing more MDR bacteria was cultivated (5.9 vs. 20.9%; p < 0.0001). CONCLUSIONS: Although they occur less frequently in appendectomy compared to emergency surgeries for other abdominal diseases, MDR bacteria are traceable in this common disease and contribute to additional morbidity.


Asunto(s)
Apendicitis/microbiología , Bacterias/aislamiento & purificación , Infecciones Bacterianas/microbiología , Farmacorresistencia Bacteriana Múltiple , Enfermedad Aguda , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Apendicectomía/métodos , Apendicitis/diagnóstico , Apendicitis/cirugía , Bacterias/efectos de los fármacos , Infecciones Bacterianas/diagnóstico , Infecciones Bacterianas/cirugía , Niño , Femenino , Humanos , Laparoscopía , Tiempo de Internación , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
15.
Ann Surg Oncol ; 23(9): 2849-57, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27059026

RESUMEN

BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide. Growing evidence indicates that tumor-initiating cells (TICs) are responsible for tumor growth and progression. Conventional chemotherapeutics do not sufficiently eliminate TICs, leading to tumor relapse. We aimed to gain insight into TIC biology by comparing the transcriptome of primary TIC cultures and their normal stem cell counterparts to uncover expression differences. METHODS: We established colonosphere cultures derived from the resection of paired specimens of primary tumor and normal mucosa in patients with CRC. These colonospheres, enriched for TICs, were used for differential transcriptome analyses to detect new targets for a TIC-directed therapy. Effects of target inhibition on CRC cells were studied in vitro and in vivo. RESULTS: Pathway analysis of the regulated genes showed enrichment of genes central to PI3K/AKT and Wnt-signaling. We identified CD133 as a marker for a more aggressive CRC subpopulation enriched with TICs in SW480 CRC cells in an in vivo cancer model. Treatment of CRC cells with the selective AKT inhibitor MK-2206 caused a decrease in cell proliferation, particularly in the TIC fraction, resulting in a significant reduction of the stemness capacity to form colonospheres in vitro and to initiate tumor formation in vivo. Consequently, MK-2206 treatment of mice with established xenograft tumors exhibited a significant deceleration of tumor progression. Primary patient-derived tumorsphere growth was significantly inhibited by MK-2206. CONCLUSION: This study reveals that AKT signaling is critical for TIC proliferation and can be efficiently targeted by MK-2206 representing a preclinical therapeutic strategy to repress colorectal TICs.


Asunto(s)
Antineoplásicos/farmacología , Neoplasias Colorrectales/tratamiento farmacológico , Compuestos Heterocíclicos con 3 Anillos/farmacología , Células Madre Neoplásicas/efectos de los fármacos , Proteínas Proto-Oncogénicas c-akt/genética , Antígeno AC133/metabolismo , Animales , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Colon/citología , Neoplasias Colorrectales/metabolismo , Fluorouracilo/farmacología , Perfilación de la Expresión Génica , Humanos , Mucosa Intestinal/citología , Ratones , Ratones Endogámicos NOD , Ratones SCID , Trasplante de Neoplasias , Fosfatidilinositol 3-Quinasas/genética , Fosfatidilinositol 3-Quinasas/metabolismo , Cultivo Primario de Células , Proteínas Proto-Oncogénicas c-akt/antagonistas & inhibidores , Proteínas Proto-Oncogénicas c-akt/metabolismo , Esferoides Celulares/efectos de los fármacos , Transcriptoma , Proteína p53 Supresora de Tumor/genética , Vía de Señalización Wnt/genética
16.
BMC Cancer ; 16: 325, 2016 05 23.
Artículo en Inglés | MEDLINE | ID: mdl-27215551

RESUMEN

BACKGROUND: Transarterial chemoembolization is one of the most widely accepted interventional treatment options for treatment of hepatocellular carcinoma. Still there is a lack of a standard protocol regarding the injected chemotherapeutics. Survivin is an inhibitor of Apoptosis protein that functions to inhibit apoptosis, promote proliferation, and enhance invasion. Survivin is selectively up-regulated in many human tumors. Small interfering RNA (siRNA) can trigger an RNA interference response in mammalian cells and induce strong inhibition of specific gene expression including Survivin. The aim of the study is to assess the effectiveness of the additional injection of Survivin siRNA to the routine protocol of Transarterial Chemoembolization (TACE) for the treatment of hepatocellular carcinoma in a rat model. METHODS: The study was performed on 20 male ACI rats. On day 0 a solid Morris Hepatoma 3924A was subcapsullary implanted in the liver. On day 12 MRI measurement of the initial tumor volume (V1) was performed. TACE was performed on day 13. The rats were divided into 2 groups; Group (A, n = 10) in which 0.1 mg mitomycin, 0.1 ml lipiodol and 5.0 mg degradable starch microspheres were injected in addition 2.5 nmol survivin siRNA were injected. The same agents were injected in Group (B,=10) without Survivin siRNA. MRI was repeated on day 25 to assess the tumor volume (V2). The tumor growth ratio (V2/V1) was calculated. Western blot and immunohistochemical analysis were performed. RESULTS: For group A the mean tumor growth ratio (V2/V1) was 1.1313 +/- 0.1381, and was 3.1911 +/- 0.1393 in group B. A statistically significant difference between both groups was observed regarding the inhibition of tumor growth (P < 0.0001) where Group A showed more inhibition compared to Group B. Similarly immunohistochemical analysis showed significantly lower (p < 0.002) VEGF staining in group A compared to group B. Western Blot analysis showed a similar difference in VEGF expression (P < 0.0001). CONCLUSION: The additional injection of Survivin siRNA to the routine TACE protocol increased the inhibition of the hepatocellular carcinoma growth in a rat animal model compared to regular TACE protocol.


Asunto(s)
Carcinoma Hepatocelular/terapia , Quimioembolización Terapéutica/métodos , Aceite Etiodizado/administración & dosificación , Proteínas Inhibidoras de la Apoptosis/antagonistas & inhibidores , Neoplasias Hepáticas/terapia , Mitomicina/administración & dosificación , ARN Interferente Pequeño/administración & dosificación , Animales , Terapia Combinada/métodos , Aceite Etiodizado/uso terapéutico , Humanos , Inyecciones Intraarteriales , Masculino , Mitomicina/uso terapéutico , Trasplante de Neoplasias , ARN Interferente Pequeño/farmacología , Ratas , Ratas Endogámicas ACI , Survivin , Resultado del Tratamiento
17.
Langenbecks Arch Surg ; 401(2): 239-47, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26931517

RESUMEN

PURPOSE: Resident participation in operative procedures is mandatory in educational residency programs but remains controversial, especially in the context of patient safety. This study compared the surgical quality and outcomes of thyroidectomies performed by surgical residents (RESs) and board-certified surgeons (BCSs). METHODS: This retrospective matched-pair study included patients undergoing thyroidectomies for multinodular goiter, Grave's disease and early-stage thyroid cancer that were performed by a RES with BCS supervision between 2006 and 2014. The intraoperative and postoperative course, complication rates and handling of the recurrent laryngeal nerve (RLN) and parathyroid glands were analyzed. RESULTS: In total, 112 thyroidectomies that were performed by a RES fulfilled the inclusion criteria and were matched 1:1 with BCS patients. We included 88 hemithyroidectomies, 80 subtotal thyroidectomies and 56 total thyroidectomies. No significant differences in the handling of the RLN or parathyroid glands, the rates of postoperative RLN palsies or the rates of hypocalcaemia were found. No intraoperative complications led to the replacement of the RES as the surgeon-in-charge. Three RES and two BCS patients experienced postoperative haemorrhages (p = 0.205), and three surgical site infections (p = 1.000) occurred in each group. The mean operative time and the length of stay did not differ significantly between the two groups. CONCLUSIONS: Major aspects of patient safety in thyroid surgery are not affected by resident participation. Thyroidectomies performed by RES are not significantly longer and reveal no differences in length of stay or complication rates. The economic burden of resident involvement is modest.


Asunto(s)
Internado y Residencia , Complicaciones Posoperatorias/epidemiología , Especialidades Quirúrgicas , Enfermedades de la Tiroides/cirugía , Tiroidectomía/educación , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Competencia Clínica , Femenino , Humanos , Tiempo de Internación , Masculino , Análisis por Apareamiento , Persona de Mediana Edad , Tempo Operativo , Estudios Retrospectivos , Enfermedades de la Tiroides/patología , Tiroidectomía/efectos adversos , Adulto Joven
19.
Strahlenther Onkol ; 191(1): 7-16, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25252602

RESUMEN

BACKGROUND: In nonrandomized trials, neoadjuvant treatment was reported to prolong survival in patients with pancreatic cancer. As neoadjuvant chemoradiation is established for the treatment of rectal cancer we examined the value of neoadjuvant chemoradiotherapy in pancreatic cancer in a randomized phase II trial. Radiological staging defining resectability was basic information prior to randomization in contrast to adjuvant therapy trials resting on pathological staging. PATIENTS AND METHODS: Patients with resectable adenocarcinoma of the pancreatic head were randomized to primary surgery (Arm A) or neoadjuvant chemoradiotherapy followed by surgery (Arm B), which was followed by adjuvant chemotherapy in both arms. A total of 254 patients were required to detect a 4.33-month improvement in median overall survival (mOS). RESULTS: The trial was stopped after 73 patients; 66 patients were eligible for analysis. Twenty nine of 33 allocated patients received chemoradiotherapy. Radiotherapy was completed in all patients. Chemotherapy was changed in 3 patients due to toxicity. Tumor resection was performed in 23 vs. 19 patients (A vs. B). The R0 resection rate was 48% (A) and 52% (B, P = 0.81) and (y)pN0 was 30% (A) vs. 39% (B, P = 0.44), respectively. Postoperative complications were comparable in both groups. mOS was 14.4 vs. 17.4 months (A vs. B; intention-to-treat analysis; P = 0.96). After tumor resection, mOS was 18.9 vs. 25.0 months (A vs. B; P = 0.79). CONCLUSION: This worldwide first randomized trial for neoadjuvant chemoradiotherapy in pancreatic cancer showed that neoadjuvant chemoradiation is safe with respect to toxicity, perioperative morbidity, and mortality. Nevertheless, the trial was terminated early due to slow recruiting and the results were not significant. ISRCTN78805636; NCT00335543.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Quimioradioterapia Adyuvante/mortalidad , Recurrencia Local de Neoplasia/mortalidad , Recurrencia Local de Neoplasia/prevención & control , Pancreatectomía/mortalidad , Neoplasias Pancreáticas/mortalidad , Neoplasias Pancreáticas/terapia , Adulto , Distribución por Edad , Anciano , Quimioradioterapia Adyuvante/métodos , Cisplatino/administración & dosificación , Desoxicitidina/administración & dosificación , Desoxicitidina/análogos & derivados , Femenino , Alemania/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Terapia Neoadyuvante/mortalidad , Pancreatectomía/métodos , Neoplasias Pancreáticas/diagnóstico , Prevalencia , Estudios Prospectivos , Factores de Riesgo , Distribución por Sexo , Tasa de Supervivencia , Suiza/epidemiología , Resultado del Tratamiento , Gemcitabina
20.
Int J Colorectal Dis ; 29(6): 709-14, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24407267

RESUMEN

PURPOSE: Wound infections affect not only the individual patient but lead to an increase in medical costs. After ileostomy reversal, surgical site infections are a common problem. The objective of the study was to compare the infection rates of purse-string and conventional skin closure techniques in a high volume setting. METHODS: Patients undergoing ileostomy reversal at the Goethe University Hospital between January 2009 and August 2012 were retrospectively analysed regarding surgical site infections and associated risk factors. Patients received either conventional skin closure (running, interrupted or stapled suturing; group C) or subcuticular purse-string suture (group PS). RESULTS: In total, 114 patients have been analysed. Conventional wound closure was performed in 81 patients and 33 patients received purse-string skin closure. The groups did not differ regarding age, gender, indication for ileostomy, previous chemotherapy, and operation time. Median hospital stay was 7 days (3-34) in group PS and 8 (3-53) in group C (p = 0.15). Wound infections only occurred in groups C (n = 10, 12 %) compared to group PS (n = 0; 0 %; p = 0.034), and the wound closure technique was the only significant factor associated with surgical site infection. Surgery performed by a resident under supervision was not a risk factor for complications compared to the procedure done by a senior surgeon (p = 0.73). CONCLUSION: This study reveals an advantage of the purse-string skin closure technique in ileostomy reversals analysing a large cohort of patients. Therefore, we recommend the use of the purse-string skin closure in ileostomy reversals as one way to lower wound infection rates.


Asunto(s)
Ileostomía/efectos adversos , Infección de la Herida Quirúrgica/epidemiología , Técnicas de Sutura , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Alemania/epidemiología , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Reoperación , Estudios Retrospectivos , Infección de la Herida Quirúrgica/etiología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA